Remove 2015 Remove Digital Health Remove Drug Development Remove Pharmaceuticals
article thumbnail

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Lars Staal Wegner, M.D.

BioTech 88
article thumbnail

Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.

Digital Health Global

a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI). Contacts Media Contact: Massive Bio Erkan Terzi Chief Marketing Officer +1 844 627 7246 pr@massivebio.com